Related Experiment Video

Updated: Apr 27, 2026

Generation of Induced Pluripotent Stem Cells from Human Melanoma Tumor-infiltrating Lymphocytes
10:03

Generation of Induced Pluripotent Stem Cells from Human Melanoma Tumor-infiltrating Lymphocytes

Published on: November 11, 2016

7.9K

Notch inhibition allows oncogene-independent generation of iPS cells

Justin K Ichida1,2,3, Julia Tcw1,2,4, Luis A Williams1,2

  • 1Harvard Stem Cell Institute, Department of Stem Cell and Regenerative Biology, Harvard University, Cambridge, MA 02138, USA.

Nature Chemical Biology
|June 23, 2014
PubMed

Insights

Inhibiting the Notch pathway improves induced pluripotent stem cell (iPSC) generation efficiency. This method avoids dangerous oncogenes and maintains tumor suppressor gene activity, leading to safer human iPSCs.

Area of Science:

  • Stem cell biology
  • Developmental biology
  • Biomedicine

Background:

  • Induced pluripotent stem cell (iPSC) technology offers significant biomedical potential.
  • Current human iPSC generation is inefficient, often requiring oncogenes (KLF4, CMYC) or p53 inhibition.
  • p53 is a critical tumor suppressor gene, and its inhibition raises safety concerns.

Purpose of the Study:

  • To enhance the efficiency of iPSC generation from somatic cells.
  • To develop safer methods for generating human iPSCs, avoiding oncogenes and p53 manipulation.
  • To investigate the role of developmental signaling pathways in reprogramming.

Main Methods:

  • Hypothesized that inhibiting differentiation-promoting pathways could improve reprogramming.
  • Utilized pharmacological inhibition of the Notch signaling pathway in mouse and human keratinocytes.
  • Assessed iPSC generation efficiency, p21 suppression, p53 activity, and cell self-renewal capacity.

Main Results:

  • Notch inhibition significantly improved iPSC generation efficiency in both mouse and human keratinocytes.
  • Notch inhibition suppressed p21 expression in a p53-independent manner.
  • This approach enabled routine production of human iPSCs without KLF4 and CMYC, while preserving p53 function.

Conclusions:

  • Restricting somatic cell differentiation by inhibiting Notch signaling enhances iPSC reprogramming.
  • This strategy provides a safer alternative for generating human iPSCs, avoiding oncogenes and preserving p53.
  • Altering intercellular communication pathways is a promising approach for safer stem cell therapies.

More Related Videos

Integration of Bioinformatics Approaches and Experimental Validations to Understand the Role of Notch Signaling in Ovarian Cancer09:08

Integration of Bioinformatics Approaches and Experimental Validations to Understand the Role of Notch Signaling in Ovarian Cancer

Published on: January 12, 2020

6.3K
Directed Differentiation of Induced Pluripotent Stem Cells towards T Lymphocytes12:47

Directed Differentiation of Induced Pluripotent Stem Cells towards T Lymphocytes

Published on: May 14, 2012

18.2K

Related Concept Videos

Notch Signaling Pathway03:14

Notch Signaling Pathway

The Notch signaling pathway is a major intracellular signaling pathway that is highly conserved over a broad spectrum of metazoan species. It stands unique from other intracellular signaling mechanisms in animals because notch protein itself acts as the receptor as well as the primary signaling molecule.
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not...
4.6K
Notch Signaling Pathway03:14

Notch Signaling Pathway

4.9K
Role Of Notch Signalling In Intestinal Stem Cell Renewal01:12

Role Of Notch Signalling In Intestinal Stem Cell Renewal

Notch signaling was first discovered in Drosophila melanogaster, where it is involved in cell lineage differentiation. Notch signaling regulates the maintenance and differentiation of intestinal stem cells or ISCs by controlling the expression of atonal homolog 1 or Atoh1. Atoh1 directs cells to differentiate into secretory cells.
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
1.8K
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
8.9K
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
4.8K
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
4.9K